SEC Form SC 13G/A filed by GenMark Diagnostics, Inc. (Amendment)

5/10/21 11:58:21 AM ET

Medical/Dental Instruments

Health Care

Get the next $GNMK alert in real time by email

SC 13G/A 1 gnmk521.txt SCHEDULE 13G Amendment No. 1 Name of Issuer: GenMark Diagnostics Inc. Title of Class of Securities: Common Stock CUSIP Number: 372309104 Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 0 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 0 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 0 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 0.0% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: GenMark Diagnostics Inc. Item l(b): Address of Issuer: 5964 La Place Court, Carlsbard, CA 92008 Item 2(a): Name of Person Filing: Wasatch Advisors, Inc. Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 372309104 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 0 Item 4(b): Percent of Class Owned: 0.0% Item 4(c)(i): Sole Voting Power: 0 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 0 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [X] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of April 30, 2021. Date: 05/10/21 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO

Get the next $GNMK alert in real time by email

SEC Form SC 13G/A filed by GenMark Diagnostics, Inc. (Amendment)

5/10/21 11:58:21 AM ET

$GNMK

Medical/Dental Instruments

Health Care

Get the next $GNMK alert in real time by email

SEC Form SC 13G/A filed by GenMark Diagnostics, Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$GNMK

SEC Form SC 13G/A filed by GenMark Diagnostics, Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$GNMK

$GNMK
SEC Filings

SEC Form 15-12B filed by GenMark Diagnostics, Inc.

SEC Form EFFECT filed by GenMark Diagnostics, Inc.

SEC Form S-8 POS filed by GenMark Diagnostics, Inc.

$GNMK
Insider Trading

SEC Form 4: Giles Lisa M. decreased direct ownership by 100% to 0 units to satisfy tax liability

SEC Form 4: Fox James decreased direct ownership by 100% to 0 units to cover taxes

SEC Form 4: Kagnoff Michael decreased direct ownership by 100% to 0 units to satisfy tax liability

$GNMK
Press Releases

Gene Panel Market size worth $ 8.22 Million, Globally, by 2028 at 21.36% CAGR: Verified Market Research®

Roche commences tender offer for all shares of GenMark Diagnostics, Inc. for $24.05 per share in cash

Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample

$GNMK
Analyst Ratings

GenMark Diagnostics downgraded by BTIG

GenMark Diagnostics downgraded by Cowen & Co. with a new price target

GenMark Diagnostics downgraded by Canaccord Genuity

$GNMK
Large Ownership Changes